MedTrace Logo

Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation

NCT02082548 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2374

Last updated 2017-11-13

No results posted yet for this study

Summary

To determine whether a comprehensive evaluation and customized multilevel educational interventions will increase the rate of use of oral anticoagulants and the adherence and persistence of use in patients with atrial fibrillation. Our hypothesis is that there will be differences in the use of oral anticoagulants and the persistence in patients between the control and interventional group. There will be a greater change in the use of oral anticoagulants over one year in the cohort in the intervention sites than the control sites. This will be due to two factors: greater initiation of oral anticoagulants among patients not treated at baseline and greater persistence of treatment for those on treatment at baseline

Conditions

Interventions

OTHER

Educational Intervention

This intervention will contain educational materials for both patients and providers that are specific to the needs in each participating country

Sponsors & Collaborators

Principal Investigators

  • Christopher B Granger, MD · Duke Clinical Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2017-05-09
Completion
2017-05-09

Countries

  • Argentina
  • Brazil
  • China
  • India
  • Romania

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02082548 on ClinicalTrials.gov